Skip to Main Content

Paper Details

Circulating Isovalerylcarnitine and Lung Cancer Risk: Evidence from Mendelian Randomization and Prediagnostic Blood Measurements.
Cancer Epidemiol Biomarkers Prev
5
2022
IVC, Isovalerylcarnitine, L-carnatine, Lung Cancer, Mendelian disease, blood, cancer, glycine, isovaleric, isovaleric acidemia, isovalerylcarnitine, lung cancer, lung cancers
Author NameAffiliation
Christoph H BorchersMcGill University, Canada/Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital
Christoph H BorchersUniversity of Victoria-Genome British Columbia Proteomics Centre, University of Victoria
Christoph H BorchersMcGill University, Canada/Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital
Christoph H BorchersUniversity of Victoria-Genome British Columbia Proteomics Centre, University of Victoria
Christopher I AmosDan L Duncan Comprehensive Cancer Center, Baylor College of Medicine
Christopher I AmosDan L Duncan Comprehensive Cancer Center, Baylor College of Medicine
Rayjean J HungMount Sinai Hospital
Rudolf KaaksGerman Cancer Research Center (DKFZ)
Rudolf KaaksTranslational Lung Research Center (TLRC) Heidelberg, Member of the German Center for Lung Research (DZL)
Matthias B SchulzeGerman Institute of Human Nutrition Potsdam-Rehbruecke (DIfE)
Matthias B SchulzeUniversity of Potsdam, Institute of Nutritional Science
Ruth C TravisUniversity of Oxford
John Brent RichardsMcGill University, Canada/Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital
John Brent RichardsMcGill University
John Brent RichardsKing's College London
John Brent RichardsMcGill University, Canada/Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital
John Brent RichardsMcGill University
John Brent RichardsKing's College London
  • 1 - 18

Datasets